A stem cell-based product consisting of allogeneic mobilized peripheral blood mononuclear stem and immune cells collected by apheresis from the donor.

‍

The cells are processed to reduce the numbers of mature donor T cells, which can cause Graft versus Host Disease (GvHD), while keeping the necessary hematopoietic progenitor cells and facilitating cells needed for engraftment into the patient's marrow.

‍

For more information on FCR001, visit the resources page.